
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Pharmacists hoping to become certified to train their diabetes patients to use insulin pumps must wear the devices themselves, under a project sponsored by Diabetes in Control.com.






